Johnson Matthey (LON:JMAT – Get Free Report) had its price objective upped by equities researchers at Berenberg Bank from GBX 2,100 to GBX 2,300 in a research report issued to clients and investors on Monday,Digital Look reports. The firm currently has a “buy” rating on the stock. Berenberg Bank’s price objective would indicate a potential upside of 7.30% from the company’s previous close.
JMAT has been the topic of several other research reports. Deutsche Bank Aktiengesellschaft boosted their price target on Johnson Matthey from GBX 2,120 to GBX 2,400 and gave the company a “buy” rating in a research note on Friday. UBS Group reiterated a “neutral” rating and set a GBX 2,200 price target on shares of Johnson Matthey in a research note on Friday, May 22nd. Finally, Jefferies Financial Group reiterated a “restricted” rating on shares of Johnson Matthey in a research note on Friday. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of GBX 2,298.33.
Check Out Our Latest Report on JMAT
Johnson Matthey Stock Up 1.1%
Johnson Matthey (LON:JMAT – Get Free Report) last posted its quarterly earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share for the quarter. The business had revenue of GBX 1,257.30 billion for the quarter. Johnson Matthey had a negative return on equity of 4.66% and a negative net margin of 0.76%. Equities analysts anticipate that Johnson Matthey will post 173.4112903 EPS for the current year.
Insider Transactions at Johnson Matthey
In other Johnson Matthey news, insider Liam Condon purchased 14 shares of Johnson Matthey stock in a transaction that occurred on Wednesday, March 11th. The stock was bought at an average price of GBX 1,941 per share, with a total value of £271.74. Also, insider Alastair Judge purchased 14 shares of Johnson Matthey stock in a transaction that occurred on Wednesday, April 15th. The stock was acquired at an average cost of GBX 2,022 per share, with a total value of £283.08. Insiders purchased a total of 72 shares of company stock valued at $146,198 in the last ninety days. 0.51% of the stock is currently owned by insiders.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Read More
- Five stocks we like better than Johnson Matthey
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
